Document is current
Any future updates will be listed below
-
Authors
Nakatoh, Shinichi https://orcid.org/0000-0001-7928-0014
Fujimori, Kenji
Ishii, Shigeyuki
Tamaki, Junko
Okimoto, Nobukazu
Ogawa, Sumito
Iki, Masayuki
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 8 December 2025
First Online: 19 December 2025
Declarations
:
: This study was conducted per the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Osaka Medical and Pharmaceutical University (approval number: 2023–038).
: Our data were completely anonymous. Therefore, informed consent from each patient was not required.
: The present study is not registered.
: N. Okimoto received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd. and Teijin Pharma Ltd., and payments for the lectures, including speakers’ bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd., Amgen Astellas Bio Pharma K.K., Astellas Pharma Inc., Chugai Pharmaceutical Co., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan, and Teijin Pharma Ltd. All other authors have no conflicts of interest.
